Sale!

GDAP1 Gene CMT4A Genetic Test

4,400 د.إ

-21%

The GDAP1 Gene CMT4A Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the GDAP1 gene, which are responsible for Charcot-Marie-Tooth disease type 4A (CMT4A). CMT4A is a rare subtype of Charcot-Marie-Tooth disease, a group of hereditary disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the arms and legs. The GDAP1 gene plays a crucial role in the functioning of peripheral nerves, and mutations in this gene disrupt nerve transmission, causing the symptoms associated with CMT4A.

The test is conducted at DNA Labs UAE, a leading facility in genetic testing, ensuring high standards of accuracy and reliability. With a cost of 4400 AED, the GDAP1 Gene CMT4A Genetic Test is an essential tool for individuals with a family history of Charcot-Marie-Tooth disease or those exhibiting symptoms consistent with peripheral neuropathies. Early and accurate diagnosis through this genetic test can aid in the management of the condition, allowing for targeted interventions and informed genetic counseling for affected families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GDAP1 Gene CMT4A Genetic Test

At DNA Labs UAE, we offer the GDAP1 Gene CMT4A Genetic Test for individuals who may be at risk for Charcot-Marie-Tooth disease type 4A (CMT4A). This rare genetic disorder affects the peripheral nerves and can cause muscle weakness, atrophy, and loss of sensation in the hands and feet.

Test Details

The GDAP1 Gene CMT4A Genetic Test is a next-generation sequencing (NGS) test that analyzes the GDAP1 gene for mutations associated with CMT4A. This test can help diagnose CMT4A in individuals with symptoms and can also be used for carrier testing in individuals with a family history of CMT4A.

Components

  • Test Name: GDAP1 Gene CMT4A Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Symptoms and Diagnosis

Individuals who may benefit from the GDAP1 Gene CMT4A Genetic Test are those experiencing symptoms such as muscle weakness, atrophy, and loss of sensation in the hands and feet. To ensure accurate diagnosis, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with GDAP1 Gene CMT4A.

Cost

The cost of the GDAP1 Gene CMT4A Genetic Test is 4400.0 AED.

Importance of Early Diagnosis and Management

Early diagnosis and management of CMT4A can significantly improve the quality of life for individuals affected by this genetic disorder. It can also help prevent further complications. By identifying the specific mutations in the GDAP1 gene, healthcare professionals can provide personalized treatment plans and interventions.

If you suspect that you or a loved one may be at risk for CMT4A, we recommend consulting with a neurologist who can guide you through the testing process and provide appropriate care.

Test Name GDAP1 Gene CMT4A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GDAP1 Gene CMT4A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GDAP1 Gene CMT4A
Test Details

The GDAP1 gene is associated with Charcot-Marie-Tooth disease type 4A (CMT4A), a rare genetic disorder that affects the peripheral nerves. The CMT4A NGS genetic test is a next-generation sequencing test that analyzes the GDAP1 gene for mutations that can cause CMT4A. This test can help diagnose CMT4A in individuals with symptoms such as muscle weakness, atrophy, and loss of sensation in the hands and feet. It can also be used for carrier testing in individuals with a family history of CMT4A. Early diagnosis and management of CMT4A can improve quality of life and prevent further complications.